Study of Fasting Plasma Glucose (FPG) for Prediction of Feto-maternal outcome in Pregnant Women between 24 to 32 wks Gestation

Background The longitudinal changes in carbohydrate metabolism during gestation are integral for successful pregnancy outcome for both mother and fetus. Fasting blood glucose between 24 to 36 weeks gestation have been found to be a good screening test for GDM in many studies and helpful in prediction of feto- maternal outcome. Methods The present study deals with 500 consenting pregnant women with gestational age between 24 to 32 weeks enrolled in the Antenatal outpatient department (OPD) of Obstetrics and Gynaecology, New Civil Hospital, Surat from 1st Nov, 2011 to 30th Sept, 2013 studied prospectively. After a detailed history taking and examination, consent was obtained and Fasting samples were collected the next morning. Results Fasting plasma glucose is a good screening test with sensitivity 77.94 % for detection of GDM. There is a linear relationship between rising FPG and adverse feto-maternal outcome. Conclusions Fasting plasma glucose test is feasible at health centre, we can screen pregnant women for abnormal values. If they are abnormal, we can refer them to tertiary health care centre for further investigation and management. So, fasting plasma glucose test as a simple screening test, many advantages by reducing maternal morbidity as well as perinatal morbidity and mortality due to GDM from a group of people who are far from tertiary health care.